INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
DS
Corporate insider

Dreyer Scott

EVP & Chief Commercial OfficerCIK 0001746251

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 2
Max Insider Score20
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Option exercise · 10b5-1 plan
M$280K
17.6K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    COLLEGIUM PHARMACEUTICAL, INCEVP & Chief Commercial Officer · Dec 10, 2025
20
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Open-market sale · 10b5-1 plan
SELL
$533K
11.1K sh
Dec 8, 2025
Dec 10, 2025
traded Dec 8, 2025
+2d
SEC FORM 4

Evidence

20
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Open-market sale · 10b5-1 plan
SELL$315K
6,475 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence

0
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Option exercise · 10b5-1 plan
M—
17.6K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence